NASDAQ · Biotechnology

JSPR (JSPR) Stock

$0.63 +1.48% NASDAQ: JSPR Healthcare

Valuation

MetricValue
Price$0.63
Market Cap$10.24M
P/E Ratio-0.21
P/B Ratio3.32
P/S Ratio0.00
EPS (TTM)$-3.95
52-Week High$7.19
52-Week Low$0.32
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-1900.00%
ROA-211.11%
ROCE-2025.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.22
Current Ratio2.69

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-37.0M$-51.0M$-69.0M$-76.0M$-81.0M
Net Profit$-31.0M$-38.0M$-64.0M$-71.0M$-76.0M
EPS$-26.89$-10.33$-6.18$-4.89$-3.95
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$94.0M$48.0M$95.0M$80.0M$36.0M
Total Liabilities$24.0M$12.0M$16.0M$18.0M$32.0M
Cash$85.0M$38.0M$87.0M$72.0M$29.0M
Borrowings$3.0M$4.0M$3.0M$2.0M$1.0M

Latest News

Chronic Spontaneous Urticaria Market Heats Up as Pharma Companies Race to Address Unmet Needs | DelveInsight PR Newswire · Jun 24, 2026 Bears are Losing Control Over Jasper Therapeutics (JSPR), Here's Why It's a 'Buy' Now Zacks · Jun 3, 2026 Sector Update: Healthcare Stocks Fall Late Afternoon MT Newswires · Jun 1, 2026 Sector Update: Healthcare Stocks Fall in Afternoon Trading MT Newswires · Jun 1, 2026 Sector Update: Healthcare MT Newswires · Jun 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-46.0M$-52.0M$-63.0M$-77.0M
Investing Cash Flow$-5.0M$-1.0M$-1.0M$-1.0M$0
Financing Cash Flow$90.0M$0$-1.0M$1.0M$0
Net Cash Flow$65.0M$-46.0M$49.0M$-15.0M$-43.0M
Free Cash Flow$-36.0M$-46.0M$-52.0M$-63.0M$-77.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-493.05%
Quick Ratio2.26
Interest Coverage—
Return 1Y-79.09%
Return 3Y-95.09%
Return 5Y-99.30%

Ownership

Insiders Held1.19%
Institutions Held56.57%
Institutions Float Held57.25%
Institutional HolderSharesReport Date
Velan Capital Investment Management LP2,668,3952026-03-31
Millennium Management Llc1,617,5312026-03-31
Acorn Capital Advisors, LLC 1,411,4922026-03-31
Kingdon Capital Management LLC1,352,1062026-03-31
Morgan Stanley1,333,4202026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BOLD $2.48 -3.50% -0.56 $55.74M 0.00%
BTAIBioXcel Therapeutics, Inc. $0.87 +2.30% -0.13 $26.77M 0.00%
CELUCelularity Inc. $0.75 +0.13% -0.20 $21.74M 0.00%
GBIOGeneration Bio Co. $5.34 +0.00% -0.87 $35.98M 0.00%
MURAMural Oncology plc $2.04 +0.00% -0.41 $35.38M 0.00%

About JSPR

JSPR is led by CEO Jeetinder Singh Mahal, employs 64 people, headquartered in US, publicly traded since 2020.

JSPR stock trades at $0.63 with a market capitalization of $10.24M. The stock is valued at a price-to-earnings (P/E) ratio of -0.21, price-to-book of 3.32, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.32 and $7.19, and currently trades 91.2% below its 52-week high.

On profitability, JSPR generates a return on equity (ROE) of -1900.00%, return on capital employed of -2025.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides